Testing

In June 2018, Mayo Medical Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • July 12, 2018

High-sensitivity troponin T is a new assay recently approved by the U.S. Food and Drug Administration. This assay is most often used to evaluate patients with possible acute ischemic heart disease, but it also has a variety of uses in the more chronic setting.

By mayocliniclabs • June 25, 2018

The following list of updates were posted to MayoMedicalLaboratories.com during the month of May 2018: […]

By Erika Fetterman • June 15, 2018

There are many probable causes of chronic diarrhea and abdominal pain, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, infectious GI pathogens, and malignancy. After excluding other causes of chronic diarrhea, a physician is left with the diagnosis IBS-diarrhea (IBS-D). One main cause of IBS-D is bile acid malabsorption.

By Alyssa Frank • June 1, 2018

The following list of updates were posted to MayoMedicalLaboratories.com during the month of April 2018.

By Erika Fetterman • May 29, 2018

In April 2018, Mayo Medical Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • May 24, 2018

To help you manage billing charges associated with test cancellations and tests not performed, Mayo Clinic Laboratories has launched a new, interactive Test Not Performed (TNP) Report.

By Andy Tofilon • May 6, 2018

Hereditary neuromuscular disorders are quite varied in their presentations and even more diverse in terms of their specific genetic causes. Sometimes, these disorders can be framed in terms of the extent of weakness, sensory involvement, and/or autonomic involvements, but in other instances, it may be difficult to discern the appropriate test for many patients based on phenotype.

By mayocliniclabs • April 24, 2018

At Mayo Clinic, we know the importance of laboratory testing in a patient’s episode of care. Our unique combination of specialized laboratories and neurology patient care clinics gives us the ability to put into practice clinically proven, cost-effective, patient care-driven testing approaches for hundreds of neurological conditions.

By mayocliniclabs • April 21, 2018

The following list of updates were posted to MayoMedicalLaboratories.com during the month of March 2018.

By Erika Fetterman • April 20, 2018

Mayo Medical Laboratories is the first clinical laboratory to offer postmortem genetic tests for inheritable cardiovascular disorders on formalin-fixed paraffin-embedded (FFPE) tissue as a preferred sample type.

By mayocliniclabs • April 10, 2018

In March 2018, Mayo Medical Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • April 5, 2018

In February 2018, Mayo Medical Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • March 15, 2018